sansero-life-getting-brighter-slider-1 of The Future Mental Healthcare

The Forefront Of Psilocybin Science

Sansero Life Sciences is a Canadian-based bioscience company developing novel medications for the evolving needs of patients and the future of mental health care.

Sansero’s highly skilled and experienced research team uses advanced machine learning, diagnostics and metabolic pathway profiling to create psilocybin-based formulations designed to replace anti-depressants and ADHD medications with new pharmaceuticals that treat the complete neurological pathway

Our Focus

Mental Health

1 in 4 will be affected by mental or neurological disorders with 450 million currently suffering from such conditions, 2/3 of which suffer from depression.

Metabolic Disease

Prevalent in the cause of diabetes, heart disease, cancer, Alzheimer’s, rheumatoid arthritis, inflammatory bowel disease, asthma, multiple sclerosis and others.

Opioid Abuse

An estimated 1.7mm people in the US alone suffered from substance use disorders related to opioid usage in 2017, leading to ~50,000 deaths due to overdose.